Skip to Content
  • About Volpi
    • News & Events
    • The Volpi Voice
    • Testimonials
    • Careers
    • Downloads
    • Webinars
  • Markets
    • Clinical Laboratory IVD Applications
    • Point-of-Care IVD Applications
    • Life Sciences Applications
  • Expertise
    • Design and Development
    • Intelligent Optics
    • Design Transfer
    • Manufacturing
    • Life Cycle Management
  • Resources
  • News & Events
  • Contact Us
  • LinkedIn
Volpi
  • News & Events
  • Contact Us
  • LinkedIn
  • Markets
    • Invitro Diagnostics (IVD) Applications
    • Life Science Applications
    • Animal Health
  • Expertise
    • Consulting
    • Design and Development
    • Design Transfer
    • Manufacturing
    • Life Cycle Management
  • Resources
    • Case Studies
    • Thought Leadership
    • Webinars
  • About Volpi
    • News & Events
    • The Volpi Voice
    • Testimonials
    • Careers Switzerland
    • Careers US
    • Sustainability
    • Downloads

May 20, 2020

  1. Home Volpi
  2. /
  3. 2020
  4. /
  5. May
  6. /
  7. 20

Volpi Technology Powers Critical Instruments to Help Fight COVID-19

May 20, 2020 News

Volpi is proud to be partnering with market leaders Ortho Clinical Diagnostics, Qiagen, Luminex, Siemens and others to contribute to the diagnosis and treatment of those afflicted with COVID-19.

Read More
Recent News Articles
September 17, 2025
Volpi Group Welcomes Marco Gadola as New Chairman of the Board
Read More »
April 7, 2025
Meet Thomas Lanz – Volpi’s new Head of R&D
Read More »
View All News »
  • Search

Volpi
News & Events
Careers
LinkedIn

United States

  • 5 Commerce Way
    Auburn, NY 13021
  • +1 315 255-1737
  • +1 315 255-1202

Switzerland

  • Lagerstrasse 10
    8953 Dietikon
    Switzerland
  • +41 44 732 43 43

© 2026 All rights reserved to Volpi Manufacturing USA, Co, Inc. and Volpi AG

Privacy Policy | Disclaimer | Terms & Conditions

This site uses cookies for site operations such as improving website experiences, analytics, and remembering preferences. By clicking "Accept" you agree to such purposes.

Privacy Policy Accept